Related Experiment Video
Updated: Aug 30, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Acetylcysteine for the prevention of radiocontrast -induced nephropathy
1Department of Medicine IV, Campus Benjamin Franklin, Charite, University of Berlin, Berlin, Germany. Tepel@zedat.fu-berlin.de
Insights
Acetylcysteine, combined with hydration, is the preferred method for preventing radiocontrast-induced nephropathy. This treatment protects kidney function following contrast media exposure in at-risk patients.
Area of Science:
- Nephrology
- Pharmacology
- Radiology
Background:
- Radiocontrast-induced nephropathy is a significant cause of acute kidney injury in hospitalized patients.
- Radiographic contrast media are increasingly used in diagnostic and therapeutic procedures.
- Preventing contrast-induced nephropathy is crucial due to patient morbidity and healthcare costs.
Purpose of the Study:
- To evaluate the efficacy of acetylcysteine in preventing radiocontrast-induced nephropathy.
- To establish the optimal method for prophylaxis against contrast-induced nephropathy.
Main Methods:
- Review of prospective, randomized, placebo-controlled studies.
- Analysis of both oral and intravenous acetylcysteine administration protocols.
- Assessment of renal function following contrast media exposure in patients with moderate renal insufficiency.
Main Results:
- Prophylactic oral acetylcysteine (600 mg twice daily) with hydration effectively prevents renal function decline post-contrast administration.
- Intravenous acetylcysteine has also demonstrated efficacy in recent studies.
- Combined acetylcysteine and hydration therapy is a proven preventative strategy.
Conclusions:
- Acetylcysteine, administered orally or intravenously along with hydration, is the treatment of choice for preventing radiocontrast-induced nephropathy.
- This regimen mitigates renal medullary ischemia and direct tubular damage.
- Effective prevention strategies are vital for managing patients undergoing procedures involving contrast media.
Abstract:
Radiocontrast-induced nephropathy is the 3rd most common cause of in-hospital acute renal failure after hypotension and surgery. Radio-graphic contrast media are used at a progressive rate for several diagnostic and therapeutic applications. Prevention of radiocontrast-induced nephropathy will become more important, including risk of patient impairment and costs. Radiocontrast-induced ne-phropathy is due to vasoconstriction-mediated renal medullary ischemia and direct toxic damage to renal tubular epithelial cells. These effects may in part be mediated by generation of reactive oxygen species. Several prospective, randomized, placebo-controlled studies in patients with moderate renal insufficiency showed that the prophylactic oral administration of acetylcysteine at a dose of 600 mg twice daily along with hydration prevents the reduction in renal function after radiocontrast administration. Recently, intravenous administration of acetyl-cysteine has also been shown to be effective. Use of acetylcysteine together with hydration is the treatment of choice to prevent radiocontrast-induced nephropathy.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Radiological Investigation I: X-ray and CT
Imaging Studies III: Computed Tomography
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury V: Interprofessional Care
Prevention of Further Absorption of Poison